Early mortality (mortality up to 90 days) · participants with alcoholic hepatitis (all severity)
It is very uncertain whether pentoxifylline changes early mortality (mortality up to 90 days) compared with no intervention (very low certainty).
1 finding from 1 review
Composite endpoint (including all‐cause mortality, non‐fatal myocardial infarction and/or any new stroke assessed at 30 days after surgery) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in composite endpoint (including all‐cause mortality, non‐fatal… compared with no RIPC (moderate certainty).
1 finding from 1 review
Days lost from work or study. · adults with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days lost from work or study. · adults with asthma
1 finding from 1 review
Ulcer healing · adults with pilonidal sinus
The review found no eligible studies for this question.
1 finding from 1 review
Ulcer healing · Men with pilonidal sinus
1 finding from 1 review
Ulcer healing · Men with pilonidal sinus
The review found no eligible studies for this question.
1 finding from 1 review
Days of unsanctioned opioid use · patients with opioid dependence
1 finding from 1 review
Short‐term all‐cause mortality (within the first 30 days after the intervention) · people with STEMI and MVD.
It is very uncertain whether complete revascularisation changes short‐term all‐cause mortality (within the first 30 days after the… compared with culprit‐only revascularisation (very low certainty).
1 finding from 1 review
Nausea · participants with advanced cancer who have nausea and vomiting not related to chemotherapy, radiotherapy, or surgery
1 finding from 1 review
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality/survival (> 30 days) · People undergoing elective abdominal aortic aneurysm repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of ICU stay · People undergoing elective abdominal aortic aneurysm repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · People undergoing elective abdominal aortic aneurysm repair
1 finding from 1 review
Chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in chronic lung disease (oxygen use at 28 days in survivors) compared with no supplementation (moderate certainty).
1 finding from 1 review
Death or chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A probably leads to lower death or chronic lung disease (oxygen use at 28 days) compared with no supplementation (moderate certainty).
1 finding from 1 review
Intervention not reported
Early mortality (90 days) · patients with diffuse emphysema
The intervention probably leads to higher early mortality (90 days) (moderate certainty).
1 finding from 1 review
Gavage to full oral feeding (days) · preterm infants
1 finding from 1 review
Start oral feeding to full oral feeding (days) · preterm infants
1 finding from 1 review